- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 25.54M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 25.69M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $785.52K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $242.27K |
| Capex | Q1 2026 · Mar 31, 2026 | $189.7K |
| Capex | Q1 2026 · Mar 31, 2025 | $441.53K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $32.94M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $9.59M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $150.12M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $102.26M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $132.95M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $425.52M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $410.37M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $385.33M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $381.9M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.16B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.15B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.58B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.56B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.27 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.28 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.26 |
| Net Income | Q1 2026 · Mar 31, 2026 | $7M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $6.41M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.23M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $1.25M |
| Revenue | Q1 2026 · Mar 31, 2026 | $79.73M |
| Revenue | Q1 2026 · Mar 31, 2025 | $82.74M |